|
시장보고서
상품코드
2032564
심장 페이스메이커 시장 : 유형, 기술, 적응증, 최종 사용자, 지역별(2026-2034년)Cardiac Pacemaker Market by Type, Technology, Indication, End User, and Region 2026-2034 |
||||||
세계의 심장 페이스메이커 시장 규모는 2025년에 53억 달러에 이르렀습니다. 향후 IMARC Group은 2034년까지 시장 규모가 71억 달러에 이르고, 2026-2034년 CAGR 3.16%를 나타낼 것으로 예측했습니다. 심혈관 질환(CVD) 유병률 증가, 건강 보험 가입자 증가, 수술 기술 향상을 위한 광범위한 조사 개발(R&:D) 활동 등이 시장을 이끄는 주요 요인 중 일부입니다.
심장 페이스메이커는 전기 펄스를 이용해 심장 박동 리듬 이상을 치료하기 위해 가슴이나 복부에 이식하는 소형 의료기기로, 심장 박동 조절 및 모니터링을 돕습니다. 마이크로프로세서, 센서, 전극, 전선, 리드, 하우징 등 전자 및 기계 부품으로 구성되어 있으며, 환자의 요구 사항에 따라 사용자 정의가 가능합니다. 부정맥이나 서맥으로 인해 발생할 수 있는 뇌졸중, 심부전 등의 합병증 위험을 줄일 수 있습니다. 또한, 심장 페이스메이커는 보다 종합적인 치료 접근법을 제공하기 위해 이식형 제세동기 및 심장 재동기화 치료 장치에 내장되어 있습니다. 현재 주요 제조업체들은 환자의 부담을 줄이고 외과 의사가 쉽게 이식할 수 있도록 소형의 저침습적 심장 페이스메이커를 도입하고 있습니다.
심장 페이스메이커 시장 동향 :
일반인 사이에서 심혈관 질환(CVD) 유병률이 급증하고 있는 것은 전 세계적으로 심장 페이스메이커 수요를 견인하는 주요 요인 중 하나입니다. 또한 부정맥, 선천성 심장병, 심방세동 등의 질환에 취약한 고령 인구 증가도 시장 성장을 견인하고 있습니다. 또한, 건강에 대한 인식이 높아지고 심장 관련 질환에 대한 치료 옵션에 대한 인식이 높아진 것도 시장에 긍정적인 영향을 미치고 있습니다. 여기에 심장 페이스메이커 비용을 보조하고 의료비를 경감시켜주는 건강 보험에 가입하는 사람들 증가도 시장 성장에 기여하고 있습니다. 또한, 주요 제조업체들은 배터리 수명이 길고 원격 모니터링 기능을 갖춘 심장 페이스메이커를 출시하고 있으며, 의료진은 스마트폰을 사용하여 기기의 성능과 환자의 심장 기능을 원격으로 추적할 수 있습니다. 주요 기업들은 또한 심박조율기 삽입에 따른 감염 및 기타 합병증 위험을 최소화하기 위해 심박조율기 제조에 생체적합성 재료를 사용하는 데 주력하고 있습니다. 또한, 심박조율기에 무선 기술을 통합하여 장치와 데이터를 송수신할 수 있게 됨으로써 장치의 정확성과 신뢰성을 향상시키는 데 기여하고 있으며, 이는 시장 성장을 가속하고 있습니다. 또한, 많은 국가의 규제 당국은 수술 기술 향상과 의료시설에 대한 접근성을 높이기 위해 연구 개발 활동에 투자하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 주요 요약
제4장 서론
제5장 세계의 심장 페이스메이커 시장
제6장 시장 분석 : 유형별
제7장 시장 분석 : 기술별
제8장 시장 분석 : 적응증별
제9장 시장 분석 : 최종 사용자별
제10장 시장 분석 : 지역별
제11장 촉진, 억제 및 기회
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
JHS 26.05.18The global cardiac pacemaker market size reached USD 5.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.16% during 2026-2034. The increasing prevalence of CVDs, rising number of people with health insurance policies, and extensive research and development (R&D) activities for improving surgical techniques represent some of the key factors driving the market.
A cardiac pacemaker is a small medical device implanted in the chest or abdomen to treat heart rhythm disorders using electrical pulses, which assist in regulating and monitoring the heartbeat. It has electronic and mechanical components, such as microprocessors, sensors, electrodes, wires, leads, and housing, and can be customized according to the requirements of the patient. It helps reduce the risk of complications like stroke and heart failure that can be caused by an irregular or slow heart rate. Besides this, a cardiac pacemaker is incorporated into implantable defibrillators and cardiac resynchronization therapy devices to offer a more comprehensive treatment approach. At present, key players are introducing small and less invasive cardiac pacemakers to make it easier for patients to tolerate and surgeons to implant.
CARDIAC PACEMAKER MARKET TRENDS:
The surging prevalence of cardiovascular diseases (CVDs) among the masses represents one of the major factors driving the demand for cardiac pacemakers around the world. Moreover, the rising aging population, which is more prone to ailments, such as arrhythmias, congenital heart disease, and atrial fibrillation, is favoring the market growth. In addition, the growing health consciousness and awareness about the available treatment alternatives for heart-related ailments are influencing the market positively. Apart from this, the increasing number of people with health insurance policies that provide financial assistance for cardiac pacemakers and reduce medical expenses is contributing to the market growth. Furthermore, leading players are launching cardiac pacemakers with longer battery life and remote monitoring capabilities that allow healthcare professionals to track the performance of the device and heart function of patients remotely using a smartphone. Key players are also focusing on using biocompatible materials in the manufacturing of cardiac pacemakers to minimize the risk of infection and other complications associated with pacemaker implantation. Besides this, the integration of wireless technology in cardiac pacemakers to transmit data to and from the device that can help improve the accuracy and reliability of the device is propelling the growth of the market. Additionally, governing agencies of numerous countries are investing in research and development (R&D) activities to improve surgical techniques and provide easy access to healthcare facilities.
KEY MARKET SEGMENTATION:
Type Insights:
- Implantable
- External
Technology Insights:
- Biventricular
- Single Chambered
- Dual Chambered
- Others
Indication Insights:
- Arrhythmias
- Congestive Heart Failure
- Others
End User Insights:
- Hospitals and Clinics
- Ambulatory Surgery Centers
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for cardiac pacemaker. Some of the factors driving the North America cardiac pacemaker market included the growing incidences of cardiac disorders, rising geriatric population, the launch of MRI-compatible pacemakers and Bluetooth-enabled pacemakers, etc.
COMPETITIVE LANDSCAPE:
The report has also provided a comprehensive analysis of the competitive landscape in the global cardiac pacemaker market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, Biotronik, Boston Scientific Corporation, Lepu Medical Technology (Beijing)Co. Ltd., MEDICO s.r.l., Medtronic plc, MicroPort Scientific Corporation, Oscor Inc. (Integer Holdings Corporation), Osypka Medical GmbH., Shree Pacetronix Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cardiac Pacemaker Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Type
- 6.1 Implantable
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 External
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Biventricular
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Single Chambered
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Dual Chambered
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Indication
- 8.1 Arrhythmias
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Congestive Heart Failure
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgery Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 Drivers, Restraints, and Opportunities
- 11.1 Overview
- 11.2 Drivers
- 11.3 Restraints
- 11.4 Opportunities
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Biotronik
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 SWOT Analysis
- 15.3.3 Boston Scientific Corporation
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Lepu Medical Technology (Beijing)Co. Ltd.
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.5 MEDICO s.r.l.
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Medtronic plc
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 MicroPort Scientific Corporation
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Oscor Inc. (Integer Holdings Corporation)
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Osypka Medical GmbH
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Shree Pacetronix Ltd.
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.1 Abbott Laboratories
